With the National Eye Institute reporting that about 11 million older adults in the U.S. endure a condition that leads to progressive blindness, known as age-related macular degeneration, University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to treat it.
New research in rats suggests a common antioxidant supplement may protect the next generation from a leading cause of blindness stemming from a high-sugar diet during pregnancy. The study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.
(New York, NY – May 10, 2021)- Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to…
As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision, according to initial data from a clinical trial.
A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye.
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
Three University of Michigan researchers say eye care accessibility around the globe isn’t keeping up with an aging population, posing challenges for eye care professionals over the next 30 years.
Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health services failed to meet World Health Organization (WHO) targets.
The method currently used to produce stem cell-derived tissues has a very limited throughput. By semi-automating tissue differentiation, researchers from MIPT and Harvard have made the process nearly four times faster, without compromising on quality. The new algorithm is also useful for analyzing the factors that affect cell specialization.
Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.
A new article published online in the Journal of the American Academy of Dermatology reveals just how common these illicit products are on popular e-commerce sites, increasing the public’s risk for severe and potentially long-term complications, including blindness, disfiguration, and stroke.
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma
Researchers now report an improved material that could take braille displays to the next level, allowing those who are blind or who have low vision to more easily understand text and images, while lowering cost.
It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.
UPMC is the first center in the U.S. to implant a wireless retinal device to treat advanced age-related macular degeneration.
Rutgers University has launched the nation’s first peer support helpline for the legally blind and their families.
University of Michigan Kellogg Eye Center is helping to save a child’s eyesight with gene therapy.
The American Academy of Ophthalmology (the Academy) and Research to Prevent Blindness (RPB) today announced this year’s recipients of the Research to Prevent Blindness/American Academy of Ophthalmology Award for IRIS® Registry Research. The grant supports researchers who want to conduct big data research in ophthalmology and blindness prevention.